Skip to main content

Therapeutic Potential of Adult Neural Stem Cells

Buy Article:

$113.00 plus tax (Refund Policy)


The central nervous system (CNS) elicits limited capacity to recover from injury. Though considerable efforts and means have been deployed to find treatments for neurological diseases, disorders and injuries, there is still no cure for these ailments, and new alternatives for therapy must be explored. Because they generate the main phenotypes of the nervous system, neural stem cells (NSCs) hold the promise to cure a broad range of neurological diseases and injuries. With the confirmation that neurogenesis occurs in the adult brain and NSCs reside in the adult CNS, new treatments for neurological diseases and injuries are being considered. Particularly, the transplantation of adult-derived neural progenitor and stem cells to restore brain functions. In this manuscript, we will review the recent developments in adult neurogenesis and NSCs, and patent applications filed in relation to discoveries made in this new field of research.

Keywords: Neural stem cells; cellular therapy; gene therapy; neurodegenerative diseases; neurogenesis; spinal cord injuries

Document Type: Research Article


Affiliations: 11 Jalan Tan Tock Seng,Singapore 308433.

Publication date: 2006-11-01

More about this publication?
  • Recent Patents on CNS Drug Discovery publishes review articles on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more